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SUMMARY
Objectives
The aim of this study was to determine the antibiotic resistance of in-
fectious and non-infectious E. coli species in order to increase the suc-
cess of empirical antibiotic treatment in urinary system infections.
Methods
The antibiotic susceptibility of 464 E. coli strains that were isolated from 
urine samples of patients who visited Derince Training and Research 
Hospital Emergency Department between January 1 and December 
31, 2012 were retrospectively evaluated from records. The antibiogram 
results were classified as susceptible, moderately susceptible or resis-
tant. Moderately susceptible strains were assumed to be resistant.
Results
Bacterial proliferation was seen in 563 (28.1%) of the 1998 urine cul-
tures tested. One hundred and twelve cultures could not be evaluated 
due to contamination, and there was no proliferation in 1323 cultures. 
E. coli strains were isolated in 464 (82.4%) of the cultures in which prolif-
eration was seen. Three hundred and sixty seven (79%) of the patients 
were female, 97 (21%) were male, and the mean age of all of the pa-
tients was 41.1±24.1 years (min: 1, max: 90). The antibiograms of the E. 
coli strains revealed that meropenem had the lowest resistance (0%), 
while ampicillin-sulbactam had the highest resistance (36.8%).
Conclusions
In this study, we investigated the antibiotic resistance of E. coli strains 
isolated from urine cultures in our region. Future studies, perhaps simi-
lar to this one, can be performed in the future to increase the success 
of treatments.
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ÖZET
Amaç
Bu çalışmada üriner sistem enfeksiyonlarında ampirik antibiyotik teda-
vi başarısını artırmak için enfeksiyon etkeni olan veya olmayan E.coli 
suşlarının çeşitli antibiyotik türlerine direnci araştırıldı.
Gereç ve Yöntem
1 Ocak-31 Aralık 2012 tarihleri arasında Derince Eğitim ve Araştırma 
Hastanesi acil servisine başvuran hastaların mikrobiyoloji laboratuva-
rına gönderilmiş idrar örneklerinden izole edilen 464 E.coli suşunun an-
tibiyotik duyarlılıkları bilgisayar kayıtları üzerinden retrospektif olarak 
değerlendirildi. Antibiyogram sonuçları duyarlı, orta duyarlı ve dirençli 
olarak sınıflandırıldı. Orta duyarlı suşlar dirençli kabul edildi.
Bulgular
1998 idrar kültüründen 563’ünde (%28.1) üreme oldu. Kültürlerin 112’si 
kontaminasyon nedeniyle değerlendirilemedi, 1323 kültürde ise üreme 
olmadı. Üreme olan kültürlerden 464’ünde (%82.4) E.coli suşları izole 
edildi. Hastaların 367’si (%79) kadın 97’si (%21) erkek, tüm hastaların 
yaş ortalaması 41.1±24.1 (min: 1, maks: 90) idi. E.coli suşlarına karşı 
antibiyogramlar incelendiğinde, direncin en düşük görüldüğü antibi-
yotik meropenem (%0), en yüksek görüldüğü antibiyotik ise ampisilin-
sulbaktam olarak saptandı (%36.8).
Sonuç
Bölgemizde idrar kültürlerinden izole edilen E.coli suşlarına karşı anti-
biyotik dirençlerini incelediğimiz çalışmamızın benzerlerinin ilerleyen 
dönemde yapılmasının tedavi başarısına yardımcı olacağını düşün-
mekteyiz.
Anahtar sözcükler: Kültür; E.coli;  acil; idrar. 
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Introduction
Urinary system infection is defined by the existence of bac-
teria in the kidneys, collecting duct system, and/or urinary 
bladder, as well as pyuria and clinical symptoms. Its severity 
ranges from asymptomatical bacteriuria to pyelonephritis.
[1] Urinary system infection is the most common type of in-
fection in adults.[2] 25-35% of women between the ages of 
20-40 years have urinary system infection,[3] and there are 5 
million attacks of cystitis in our country every year.[4] E. coli is 
present in 50-90% of these infections. Antibiotics are com-
monly used to treat urinary system infections, although they 
should be used with caution. The most important issues to 
monitor during antibiotic treatment are duration of treat-
ment, toxicity of the medication, and cost. Antibiotics used 
should not spoil the intestinal, perineal and vaginal flora, 
but should be effective against E. coli colonization.[5] Local 
antibiotic resistance should be followed up regularly in or-
der to successfully treat urinary system infections.[6] Several 
studies have shown that antibiotic resistance is increased in 
E. coli strains that cause urinary system infections. Antibiotic 
resistance is particularly common with cotrimoxazole and 
betalactams, which are relatively old molecules.[7] However, 
more recent research has indicated that resistance is increas-
ing in fluoroquinolones as well.[8] In this study, the antibiotic 
resistance of infectious and non-infectious E. coli species was 
investigated to increase the success of empirical antibiotic 
treatment in urinary system infections.
Materials and Methods 
Patients with symptoms of urinary tract infection who pre-
sented at Derince Training and Research Hospital Emergency 
Department, Turkey, between January and December 2012 
were included in this study. Clinical evidence for urinary 
tract infection included dysuria, fever, urgency, frequency, 
suprapubic or flank pain, or other clinical presentations con-
sistent with a urinary tract infection. For patients with more 
than one sample, we included only the first positive sample. 
The antibiotic susceptibility of 464 E. coli strains was retro-
spectively evaluated from hospital records. The ethics com-
mittee approved this study. The urine samples were isolated 
in a sterile way, inoculated in 5% sheep blood agar (RTA) and 
EMB (RTA) via a quantitative method, and were placed in an 
incubator (37°C) for 24-48 hours. Bacteria were detected by 
gram staining, evaluating colony morphology, and by tra-
ditional biochemical tests (TSI agar, Simmon’s citrate agar, 
movement medium, Christensen urea agar, reactions in 
indol medium, catalase, oxidase, coagulase, esculin hydro-
lysis). Bacteria were identified by an automated Phoenix 
system (BBL Becton Dickinson). Antibiotic susceptibility in 
proliferating bacteria was evaluated by the Kirby-Bauer disc 
diffusion method in accordance with the CLSI (Clinical Labo-
ratory Standards Institute) criteria using Müler-Hinton agar 
(RTA) for automated systems. Escherichia coli (ATCC 25922), 
Staphylococcus aureus (ATCC 29213), Staphylococcus aureus 
(ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853) 
were used as quality controls. The antibiogram results were 
classified as susceptible, moderately susceptible or resistant. 
Moderately susceptible strains were assumed to be resistant.
Statistical Analysis
Data from this study were recorded and evaluated using 
SPSS version 13.0 for Windows. The Chi-square test was used 
to evaluate categorical variables. Continuous variables were 
expressed as mean±standard deviation, minimum and max-
imum values were expressed as parenthetical values, and 
qualitative variables were expressed as number and per-
centage (%). P<0.05 was regarded as statistically significant.
Results
Bacterial proliferation was detected in 563 (28.1%) of the 
1998 urine cultures. One hundred and twelve cultures could 
not be evaluated due to contamination and there was no 
proliferation in 1323 cultures. E. coli strains were isolated in 
464 (82.4%) of the cultures in which there was proliferation. 
Three hundred and sixty seven (79%) of the patients were 
female, 97 (21%) were male, and the mean age of all of the 
patients was 41.1±24.1 years (min:1, max:90). Antibiograms 
of the E. coli strains revealed that the lowest resistance was 
found in cultures treated with meropenem (0%), nitrofuran-
toin (3.9%), ceftazidime (8.2%), gentamicin (8.3%), and ce-
fepime (9.5%). Those with the highest resistance included 
amoxicillin-clavulanic acid (23.4%), ampicillin-sulbactam 
(36.8%), norfloxacin (14.9%), cefazoline (15.1%), ceftriaxone 
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Table 1. Resistance rates of antibiotics
Antibiotic Resistance (%)
Meropenem 0
Nitrofurantoin 3.9
Ceftazidime 8.2
Gentamicin 8.3
Cefepime 9.5
Amoxicillin- Clavulanic Acid 23.4
Ampicillin-Sulbactam 36.8
Norfloxacin 14.9
Cefazoline 15.1
Ceftriaxone 11.1
Cefuroxime 12.9
Ciprofloxacin 17.7
Cotrimoxazole 28
(11.1%), cefuroxime (12.9%), ciprofloxacin (17.7%) and cotri-
moxazole (28%) (Table 1).
Discussion
The culture positivity ratio in our study was 28.1%, while 
those in previously published studies were 51.2% (in Ertuğrul 
et al.’s study),[4] 35% (in Gupta et al.’s study),[9] and 57.8% (in 
Pekdemir’s study).[11] We hypothesize that the difference be-
tween the results of our study and others is that we includ-
ed patients younger than 18 years, while the other studies 
did not. Urine culture is frequently used in female children 
younger than 10 years presenting to emergency service.
E. coli is the pathogen frequently responsible for urinary 
tract infection. Worldwide, the proliferation ratio of E. coli 
in urine cultures is 75-90%.[9] In our country, various studies 
have reported this ratio to be 65-80%.[10] E. coli was the most 
common pathogen (82.3%) in the current study, which is 
similar to previously reported results.
Ciprofloxacin and cotrimoxazole are antibiotics that are of-
ten used for the treatment of simple urinary tract infection. 
In our study, resistance to ciprofloxacin was 17.7%, which is 
similar to other studies, in which it was reported to be be-
tween 5-46%.[4,12,13] When compared with other antibiotics 
included in our study, ciprofloxacin is the 4th most resistant 
molecule.
Resistance to cotrimoxazole was 28% in our study, which 
was lower than that found in Güneysel’s study (34%)[14] and 
Pekdemir’s study (40.4%).[11] Cotrimoxazole was the 2nd 
most resistant antibiotic used in our study. The results of our 
study and others suggest that cotrimoxazole is very resistant 
in empirical treatment.
In our study, the resistance ratios of ampicillin-sulbactam 
(36.8%), amoxicillin-clavulonic acid (23.4%) and ciprofloxa-
cin (17.7%) were significantly higher than that of nitrofu-
rantoin (3.9%) (p<0.05). On average, nitrofurantoin is used 
at 400 mg/day in 4 equal doses to treat urinary tract infec-
tions in adults. At this concentration, it is only effective in 
the urine and kidneys, and is not effective in other tissues.[15]
Cotrimoxazole and ciprofloxacin are most often used in the 
empirical treatment of simple urinary tract infections, and 
because they are used only twice a day, patient compliance 
is higher. These antibiotics are effective in tissues other than 
the urine and kidneys. In our study and others, nitrofuran-
tion was more successful in treating urinary tract infections, 
but the guidelines of the Infectious Diseases Society of 
America (IDSA) indicate that there is no difference between 
nitrofurantoin and cotrimoxazole in seven day-treatment, 
and that more comparative studies are necessary.[16] Since 
susceptibility to nitrofurantoin is significantly high, we be-
lieve that future studies should compare its treatment with 
that of other oral antibiotics.
Limitations
One limitation of this study is its retrospective methodolo-
gy, as the urine culture indications could not be determined 
clearly from the records. In addition, because not all of the 
medical records were clear, there is a possibility that we mis-
classified some of the patients. The external validity of this 
study is also limited because it was performed in a single 
center. Centers with different demographic characteristics 
and those in different geographic regions might have differ-
ent resistance patterns.
Conclusion 
It is important to evaluate local antibiotic resistance to en-
sure the successful treatment of urinary system infections. In 
this study, we investigated the antibiotic resistance among 
E. coli strains isolated from urine cultures in our region. Fu-
ture studies similar to this can be performed in order to help 
increase the success of treatment.
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